Unknown

Dataset Information

0

Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated ?-catenin degradation in gastric cancer.


ABSTRACT:

Background

As a natural alkaloid product isolated from Sophora alopecuroides. L, Sophoridine reshapes gastric cancer immune microenvironment via inhibiting chemotaxis and M2 polarization of tumor-associated macrophages (TAMs). However, the exact effects and underlying mechanism of Sophoridine on gastric cancer cells remains poorly known.

Methods

The potential anti-tumor effects of Sophoridine on gastric cancer cell lines, including AGS and SGC7901 cells, were detected by CCK-8, EDU and colony forming assay, immunofluorescence, transwell assay, and flow cytometry. Molecular mechanisms of Sophoridine were investigated by siRNA transfection, nuclear/cytoplasmic extraction and western blot. The synergistic effects of Sophoridine with cisplatin on gastric cancer cells were further investigated in in vitro functional studies.

Results

Sophoridine exhibited potent tumor-suppressive activities in gastric cancer cells, including inhibition of proliferation, colony formulation, migration and invasion, as well as induction of apoptosis. In addition, we further showed that Sophoridine induced G2/M cell cycle arrest via inhibiting double-stranded DNA breaks repair and enhanced the efficacy of cisplatin in gastric cancer cells. Molecular studies further revealed that Sophoridine promoted ?-catenin degradation by enhancing Estrogen-related receptor gamma (ESRRG) expression, but not depended on ubiquitination-proteasome pathway, either TRIM33-mediated (GSK3?-independent) or altered GSK3? activity, and thus exerted potent tumor-suppressive activities.

Conclusion

Sophoridine depends on targeting ESRRG/?-catenin pathway to exert tumor-suppressive activities in gastric cancer cells and enhances the anti-tumor effect of cisplatin. Our study provided the promising preclinical anti-tumor evidence for the potential application of Sophoridine against gastric cancer.

SUBMITTER: Peng Z 

PROVIDER: S-EPMC7310191 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated β-catenin degradation in gastric cancer.

Peng Zhiyang Z   Guan Qing Q   Luo Jianfei J   Deng Wenhong W   Liu Jiasheng J   Yan Ruicheng R   Wang Weixing W  

BMC cancer 20200622 1


<h4>Background</h4>As a natural alkaloid product isolated from Sophora alopecuroides. L, Sophoridine reshapes gastric cancer immune microenvironment via inhibiting chemotaxis and M2 polarization of tumor-associated macrophages (TAMs). However, the exact effects and underlying mechanism of Sophoridine on gastric cancer cells remains poorly known.<h4>Methods</h4>The potential anti-tumor effects of Sophoridine on gastric cancer cell lines, including AGS and SGC7901 cells, were detected by CCK-8, ED  ...[more]

Similar Datasets

| S-EPMC7494902 | biostudies-literature
| S-EPMC9250212 | biostudies-literature
| S-EPMC7307588 | biostudies-literature
| S-EPMC7072756 | biostudies-literature
| S-EPMC7205880 | biostudies-literature
| S-EPMC10701768 | biostudies-literature
| S-EPMC7589996 | biostudies-literature
| S-EPMC8569327 | biostudies-literature
| S-EPMC2043572 | biostudies-literature
| S-EPMC3084683 | biostudies-literature